Ward Shane

CIK 00016383803 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001638380

Recent Transactions

50 trades

Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Common Stock
2026-01-07$221.50/sh−25,083→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2026-01-07−50,000→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2026-01-07−135,540→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2026-01-07−12,499→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2026-01-07−6,207→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2026-01-07−12,500→ 0 total
Exercise/Conversion
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-12-10$16.65/sh+3,500→ 28,133 total
Exercise/Conversion
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-12-10$20.20/sh+6,459→ 34,592 total
Exercise/Conversion
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2025-12-10−6,459→ 6,207 total
Sale
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-12-10$220.08/sh−9,959→ 25,033 total
Exercise/Conversion
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2025-12-10−3,500→ 0 total
Tax Payment
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-12-10$219.60/sh−15,041→ 24,633 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2025-03-31+50,000→ 50,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-03-31+25,000→ 39,674 total
Sale
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-03-11$21.96/sh−1,664→ 14,674 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2024-09-30+135,540→ 135,540 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2024-03-15+250,000→ 250,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2024-03-15+120,000→ 318,770 total
Sale
Cidara Therapeutics, Inc.$CDTX
Common Stock
2024-03-11$0.67/sh−20,473→ 198,770 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2023-03-27+126,667→ 211,243 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2023-03-27+253,333→ 253,333 total
Sale
Cidara Therapeutics, Inc.$CDTX
Common Stock
2023-03-13$1.53/sh−4,329→ 84,576 total
Tax Payment
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-03-31$0.83/sh−23,122→ 80,905 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2022-03-31+70,000→ 70,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-03-31+69,027→ 104,027 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2022-03-31+35,000→ 35,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2021-08-25+250,000→ 250,000 total
Tax Payment
BELLICUM PHARMACEUTICALS, INC
Common Stock
2020-05-29$7.63/sh−107→ 1,879 total
Award
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2020-04-08+21,864→ 21,864 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2020-02-03+410,000→ 410,000 total
Purchase
BELLICUM PHARMACEUTICALS, INC
Common Stock
2019-08-29$1.23/sh+8,000→ 18,294 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2019-06-11+45,000→ 45,000 total
Tax Payment
BELLICUM PHARMACEUTICALS, INC
Common Stock
2019-05-29$2.09/sh−1,065→ 8,935 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2019-02-01+45,000→ 45,000 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2018-05-29+120,000→ 120,000 total
Award
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-05-29+10,000→ 10,000 total
Sale
Aravive, Inc.
Common Stock
2018-02-08$1.80/sh−4,118→ 201,556 total
Award
Aravive, Inc.
Common Stock
2017-12-20+93,100→ 205,674 total
Award
Aravive, Inc.
Common Stock
2017-11-28+20,000→ 112,574 total
Sale
Aravive, Inc.
Common Stock
2017-10-19$2.55/sh−776→ 92,574 total
Award
Aravive, Inc.
Common Stock
2017-10-06+57,000→ 93,350 total
Sale
Aravive, Inc.
Common Stock
2017-03-15$19.02/sh−776→ 36,350 total
Sale
Aravive, Inc.
Common Stock
2017-03-14$19.00/sh−1,265→ 37,126 total
Sale
Aravive, Inc.
Common Stock
2017-01-30$13.85/sh−1,474→ 38,391 total
Award
Aravive, Inc.
Stock Option (Right to Buy)
2017-01-27+46,200→ 46,200 total
Award
Aravive, Inc.
Common Stock
2017-01-27+20,600→ 39,865 total
Award
Aravive, Inc.
Common Stock
2016-10-11+5,000→ 19,265 total
Award
Aravive, Inc.
Common Stock
2016-01-28+13,000→ 14,265 total
Award
Aravive, Inc.
Stock Option (Right to Buy)
2016-01-28+42,000→ 42,000 total
Award
Aravive, Inc.
Stock Option (Right to Buy)
2015-04-06+50,000→ 50,000 total

Companies

Recent Filings

Address

6310 NANCY RIDGE DRIVE SUITE 101

SAN DIEGO, CA, 92121

View on SEC.gov